Evolution and development of potent monobactam sulfonate candidate IMBZ18g as a dual inhibitor against MDR Gram-negative bacteria producing ESBLs
高效单环β-内酰胺类磺酸盐候选药物IMBZ18g作为抗产ESBLs的多重耐药革兰氏阴性菌的双重抑制剂的进化与开发
期刊:Acta Pharmaceutica Sinica B
影响因子:14.6
doi:10.1016/j.apsb.2023.03.002
Li, Zhiwen; Guo, Zhihao; Lu, Xi; Ma, Xican; Wang, Xiukun; Zhang, Rui; Hu, Xinxin; Wang, Yanxiang; Pang, Jing; Fan, Tianyun; Liu, Yonghua; Tang, Sheng; Fu, Haigen; Zhang, Jingpu; Li, Yinghong; You, Xuefu; Song, Danqing
